News & Trends - MedTech & Diagnostics
Australia’s largest private hospital operator terminates contract with health insurance giant
MedTech News: Australia’s largest private hospital operator, Ramsay Health Care, has terminated its funding agreement with health insurance giant Bupa.
On 4th May 2022, Ramsay Australia had given a notice to terminate the Hospital Purchaser Provider Agreement (HPPA) between itself and Bupa. Ramsay confirmed yesterday that the parties have been unable to reach a resolution on key elements of a new contract and as a result the contract between the two parties is now terminated.
Following termination both contractual and agreed transitional arrangements apply for a period of at least 60 days. Bupa insured patients will then be required to pay an upfront payment on admission, being the difference between the statutory default benefit Bupa is required to pay and Ramsay’s hospital treatment charges.
Ramsay is communicating with impacted patients to keep them informed and provide them with options, which in light of the portability rules in the Private Health Insurance Act include changing health funds.
According to Bupa, there are no immediate changes to the coverage for members. Bupa members remain fully covered at Ramsay hospitals until at least 1 October 2022, with some treatments including maternity and oncology, and any treatments already commenced covered up to August 2023.
Bupa Health Insurance Managing Director Chris Carroll thanked members for their patience as Bupa worked towards an agreement that put our members first and helped minimise premium increases for our members while balancing hospital costs.
“We want to move beyond this impasse and are continuing our efforts to reach an agreement that benefits our members and addresses health care costs,” he said.
“We are continuing our discussions with Ramsay and are hopeful of reaching an agreement soon. We want our members to know that our first priority in our negotiations with Ramsay has been to keep healthcare costs affordable especially when cost of living pressures continue to impact families,” he added.
The Health Industry Hub content is copyright protected and access is provided under individual user licenses. For more information, click here and visit T&Cs here.
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech join Research Australia and Digital Health CRC in welcoming funding of national strategy for medical research and National One Stop Shop
Pharma News: Medicines Australia, AusBiotech, Research Australia and the Digital Health Cooperative Research Centre (DHCRC) applaud the funding announcement of […]
MoreNews & Trends - MedTech & Diagnostics
Health insurers clash with government on GUIs decision, prompting threat of premium hikes
MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]
MoreNews & Trends - MedTech & Diagnostics
Catheter ablation underused in atrial fibrillation despite proven efficacy
MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]
MoreNews & Trends - Biotechnology
How prepared are we for the next pandemic?
Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]
More